Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 Tampilan
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan